Liver Disease

FDA Approves First Treatment For Alagille Syndrome-Associated Cholestatic Pruritus From Mirum Pharma

Precision BioSciences, iECURE Ink Licensing Pact For Gene Editing Therapies

Calliditas' Chronic Orphan Liver Disease Candidate Receives FDA Fast Track Tag

Precision BioSciences, iECURE Ink Licensing Pact For Gene Editing Therapies

Calliditas' Chronic Orphan Liver Disease Candidate Receives FDA Fast Track Tag

Dicerna Posts Updated Data From Belcesiran Early-Stage Study For Genetic Liver Disease

Albireo's Rare Liver Disease Drug Bylvay Scores Back To Back Approvals In Europe, US

Dicerna Posts Updated Data From Belcesiran Early-Stage Study For Genetic Liver Disease

Albireo's Rare Liver Disease Drug Bylvay Scores Back To Back Approvals In Europe, US

Albireo's Bylvay Scores European Nod For Rare Pediatric Liver Disease

Albireo's Bylvay Shows Further Evidence Of Sustained, Durable Effect In Pediatric Liver Disease Study

Liver Disease Recent News

Exclusive: Axcella Health Aims To Become The Standard Of Care

Axcella Health Inc (NASDAQ: AXLA) is a clinical-stage biotechnology company focused on endogenous metabolic modulators, or EEMs, said Axcella Health CEO Bill Hinshaw Thursday on Benzinga's YouTube show "Power Hour."<

Immunic's IMU-838 Shows Promising Clinical Effect In Mid-Stage Liver Disease Study

Mallinkcrodt Is Betting On Ocerta Despite Doubts Around Its Liver Disease Drug

FDA Letter On Intercept Pharma Doesn't Include Black Box Warning Label...Yet

Will Intercept Stock Potential Be Blindsided By FDA Letter?

FDA Warning Letter Buckles Intercept Pharma Shares; Wells Fargo Downgrades

Here's Why Conatus Pharmaceuticals' Stock Surged 23%

Conatus Pharmaceuticals Surges 25% Following Positive Results In Phase 2 Study

Conatus Shares Move Higher On Industry Data

Market Wrap For January 9: All Eyes on Tomorrow's Job Report